LGE and NT-proBNP Identify Low Risk of Death or Arrhythmic Events in Patients With Primary Prevention ICDs

Study Questions:

Does late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) or N-terminal pro–B-type natriuretic peptide (NT-proBNP) identify patients with a low risk of death or use of implantable cardioverter-defibrillator (ICD) in patients receiving a primary prevention ICD?